eTheRNA is a series b startup based in Belgium. 1 investor tracked.
eTheRNA is a startup founded in 2015 based in Belgium. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
eTheRNA is a clinical-stage biotechnology company developing mRNA-based immunotherapies for the treatment of cancer and infectious diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.